. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250

CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617

Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection

Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404

LPS, TLR4 and infectious disease diversity

Miller, S., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 1,059

Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage

Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

Deeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803

Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection

Jiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598

Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction

Dirajlal‐Fargo, S., Yu, J., Albar, Z., Sattar, A., Mahtab, S., Jao, J. K., Myer, L., Zar, H. J., & McComsey, G. A. (2020) · AIDS · doi:10.1097/qad.0000000000002615 · Cited by 16

Walk on the wild side: SIV infection in African non-human primate hosts—from the field to the laboratory

Jasinska, A. J., Apetrei, C., & Pandrea, I. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1060985 · Cited by 20

Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection

Karris, M., Kao, Y.-T., Patel, D. R., Dawson, M., Woods, S. P., Vaida, F., Spina, C. A., Richman, D. D., Little, S. J., & Smith, D. M. (2014) · AIDS · doi:10.1097/qad.0000000000000149 · Cited by 16

Short Communication: Evidence That Microbial Translocation Occurs in HIV-Infected Children in the United Kingdom

Fitzgerald, F., Harris, K., Doyle, R., Alber, D., & Klein, N. J. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0097 · Cited by 16

Baseline Levels of Soluble CD14 and CD16+56− Natural Killer Cells Are Negatively Associated With Response to Interferon/Ribavirin Therapy During HCV-HIV-1 Coinfection

Anthony, D. D., Conry, S. J., Medvik, K., Rani, M. R. S., Falck-Ytter, Y. T., Blanton, R. E., Lederman, M. M., Rodriguez, B. A., LANDAY, A. L., & Sandberg, J. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis434 · Cited by 16

Monocyte Activation, but not Microbial Translocation, Is Independently Associated With Markers of Endovascular Dysfunction in HIV-Infected Patients Receiving cART

Pedersen, K. K., Manner, I. W., Seljeflot, I., Kvale, D., Os, I., Gerstoft, J., Nielsen, S. D., & Trøseid, M. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000339 · Cited by 16

Treatment of HIV Infection with a Raltegravir-Based Regimen Increases LDL Levels, but Improves HDL Cholesterol Efflux Capacity

Funderburg, N., Xu, D., Playford, M. P., Joshi, A. A., Andrade, A. S., Kuritzkes, D. R., Lederman, M. M., & Mehta, N. N. (2016) · Antiviral Therapy · doi:10.3851/imp3091 · Cited by 16

Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques

Zevin, A. S., Moats, C. R., May, D., Wangari, S., Miller, C. J., Ahrens, J., Iwayama, N., Brown, M., Bratt, D., Klatt, N. R., et al. (2017) · Journal of Visualized Experiments · doi:10.3791/55617 · Cited by 16

Predict disease progression from T‐cell phenotypes in northern pig‐tailed macaques (Macaca leonina) during SIVmac239 infection

Zhang, M., Zheng, H., Jiang, J., Song, J., Chen, M., Xiao, Y., Lian, X., Song, T., Tian, R., Pang, W., et al. (2017) · Immunology · doi:10.1111/imm.12794 · Cited by 16

Caspase-1-associated immune activation in an accelerated SIV-infected rhesus macaque model

Kearns, A. C., Robinson, J. A., Shekarabi, M., Liu, F., Qin, X., & Burdo, T. H. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0630-8 · Cited by 16

Increased CMV IgG Antibody Titer is Associated with Non-AIDS Events Among Virologically Suppressed HIV-Positive Persons

Hodowanec, A. C., Lurain, N. S., Krishnan, S., Bosch, R. J., & LANDAY, A. L. (2019) · Pathogens and Immunity · doi:10.20411/pai.v4i1.255 · Cited by 16

In Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles

Bowman, E., Cameron, C., Richardson, B., Kulkarni, M., Gabriel, J., Kettelhut, A., Hornsby, L., Kwiek, J. J., Turner, A. N., Malvestutto, C., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01755-20 · Cited by 16

Immune activation and chronic inflammation

Sauce, D., Pourcher, V., Ferry, T., Boddaert, J., Slama, L., & Allavena, C. (2021) · Medicine · doi:10.1097/md.0000000000025678 · Cited by 16

Microbial Translocation Contribute to Febrile Episodes in Adults with Chemotherapy-Induced Neutropenia

Wong, M. S. Y., Barqasho, B., Öhrmalm, L., Tolfvenstam, T., & Nowak, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068056 · Cited by 16

Pattern of microbial translocation in patients living with HIV‐1 from Vietnam, Ethiopia and Sweden

Abdurahman, S., Barqasho, B., Nowak, P., Cuong, D. D., Amogne, W., Larsson, M., Lindquist, L., Marrone, G., & Sönnerborg, A. B. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.18841 · Cited by 16

Plasma Proteome Analysis Reveals Overlapping, yet Distinct Mechanisms of Immune Activation in Chronic HCV and HIV Infections

Schlatzer, D., Sugalski, J. M., Chen, Y., Barnholtz‐Sloan, J. S., Davitkov, P., Hazlett, F. E., Funderburg, N., Rodriguez, B. A., Lederman, M. M., Sieg, S. F., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182909847 · Cited by 16

A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection

Wilkinson, J. C., Ewart, G. D., Luscombe, C. A., McBride, K. L., Ratanasuwan, W., Miller, M., & Murphy, R. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv389 · Cited by 16

Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy

Yong, Y. K., Shankar, E. M., Solomon, A. E., Spelman, T. D., Fairley, C. K., Elliott, J., Hoy, J., Cameron, P. U., Kamarulzaman, A., & Lewin, S. R. (2016) · AIDS · doi:10.1097/qad.0000000000001179 · Cited by 16

Fractures and the gut microbiome

McGinty, T., & Mallon, P. W. G. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000425 · Cited by 16

Systemic immune activation in HIV and potential therapeutic options

Sinha, B., & Rubens, M. (2014) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.890217 · Cited by 15

Inflammatory and immune markers in HIV ‐infected older adults on long‐term antiretroviral therapy: Persistent elevation of sCD14 and of proinflammatory effector memory T cells

Watanabe, M., Jergović, M., Davidson, L., LaFleur, B., Castaneda, Y., Martinez, C., Smithey, M. J., Stowe, R. P., Haddad, E. K., & Nikolich‐Žugich, J. (2022) · Aging Cell · doi:10.1111/acel.13681 · Cited by 15

Unique Profile of Inflammation and Immune Activation in Pregnant People With HIV in the United States

Shiau, S., Jacobson, D. L., Huo, Y., Kacanek, D., Yee, L. M., Williams, D. B., Haddad, L. B., Serghides, L., Powis, K. M., SPERLING, R. S., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac501 · Cited by 17

The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV

Peters, B. A., Burk, R. D., Kaplan, R. C., & Qi, Q. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00648-y · Cited by 16

Long COVID as a disease of accelerated biological aging: An opportunity to translate geroscience interventions

Shafqat, A., Masters, M. C., Tripathi, U., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102400 · Cited by 15

Plasma endotoxin core antibody concentration and linear growth are unrelated in rural Malawian children aged 2–5 years

Benzoni, N. S., Korpe, P. S., Thakwalakwa, C. M., Maleta, K. M., Stephenson, K. B., Manary, M. J., & MANARY, M. J. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1238-1 · Cited by 15

Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection

Gedela, K., Vibhuti, M., Pozniak, A., Ward, B., & Boffito, M. (2013) · HIV Medicine · doi:10.1111/hiv.12116 · Cited by 15

Increased Escherichia coli-Induced Interleukin-23 Production by CD16+Monocytes Correlates with Systemic Immune Activation in Untreated HIV-1-Infected Individuals

Manuzak, J. A., Dillon, S. M., Lee, E. J., Dong, Z. M., Hecht, D. K., & Wilson, C. C. (2013) · Journal of Virology · doi:10.1128/jvi.01767-13 · Cited by 15

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

Fitzgerald, F., Lhomme, É., Harris, K., Kenny, J., Doyle, R., Kityo, C. M., Shaw, L. P., Abongomera, G., Musiime, V., Cook, A. D., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy495 · Cited by 15

Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure

Ortiz, J. A., Rubio-Garrido, M., Lozano‐Rodríguez, R., del Romero, J., Rodríguez, C., Moreno, S., Aguirre, L. A., Holguín, Á., & López‐Collazo, E. (2020) · Medicine · doi:10.1097/md.0000000000020065 · Cited by 15

Lipidome association with vascular disease and inflammation in HIV+ Ugandan children

Dirajlal‐Fargo, S., Sattar, A., Yu, J., Albar, Z., Chaves, F. C., Riedl, K. M., Kityo, C. M., Bowman, E., McComsey, G. A., & Funderburg, N. (2021) · AIDS · doi:10.1097/qad.0000000000002923 · Cited by 15

Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review

Yan, J., Ouyang, J., Isnard, S., Zhou, X., Harypursat, V., Routy, J., & Chen, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741658 · Cited by 15

Inflammation-mediated vitamin K and vitamin D effects on vascular calcifications in people with HIV on active antiretroviral therapy

Janus, S. E., Durieux, J., Hajjari, J., Carneiro, H. A., & McComsey, G. A. (2021) · AIDS · doi:10.1097/qad.0000000000003149 · Cited by 15

Circulating Muramyl Dipeptide Is Negatively Associated with Interleukin-10 in the Frail Elderly

Verschoor, C. P., Naidoo, A., Wallace, J. G., Johnstone, J., Loeb, M. B., Bramson, J. L., & Bowdish, D. M. E. (2014) · Inflammation · doi:10.1007/s10753-014-0030-z · Cited by 14

Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1–Infected Patients Starting Efavirenz, Lopinavir–Ritonavir, or Atazanavir–Ritonavir Plus Tenofovir/Emtricitabine

Miró, J. M., Manzardo, C., Ferrer, E., Loncà, M., Guardo, A. C., Podzamczer, D., Domingo, P., Curran, A., Clotet, B., Cruceta, A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000567 · Cited by 15

The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals

Rajasuriar, R., Kong, Y., Nadarajah, R., Abdullah, N., Spelman, T. D., Yuhana, M. Y., Ponnampalavanar, S. S. L., Kamarulzaman, A., & Lewin, S. R. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0391-6 · Cited by 15

Innate immune reconstitution with suppression of HIV-1

Scully, E. P., Lockhart, A. A. K., García-Beltrán, W. F., Palmer, C. D., Musante, C. D., Rosenberg, E. S., Allen, T. M., Chang, J. J., Bosch, R. J., & Altfeld, M. A. (2016) · JCI Insight · doi:10.1172/jci.insight.85433 · Cited by 15

Widespread activation of immunity and pro-inflammatory programs in peripheral blood leukocytes of HIV-infected patients with impaired lung gas exchange

Crothers, K. A., Petrache, I., Wongtrakool, C., Lee, P. J., Schnapp, L. M., & Gharib, S. A. (2016) · Physiological Reports · doi:10.14814/phy2.12756 · Cited by 15

Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection

Vidot, D. C., Manuzak, J. A., Klatt, N. R., Pallikkuth, S., Roach, M., Dilworth, S. E., Pahwa, S. G., & Carrico, A. W. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002046 · Cited by 15

Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection

Pastor, L., Langhorst, J., Schröder, D., Casellas, A., Rüffer, A., Carrillo, J., Urrea, V., Massora, S., Mandomando, I., Blanco, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218000 · Cited by 18

Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis

Chahine, A., Koru‐Sengul, T., Feaster, D. J., Dilworth, S. E., Antoni, M. H., Klatt, N. R., Roach, M. E., Pallikkuth, S., Sharkey, M. E., Salinas, J., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002560 · Cited by 15

Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study

Martínez, L. E., Lensing, S., Chang, D., Magpantay, L. I., Mitsuyasu, R. T., Ambinder, R. F., Sparano, J. A., Martı́nez-Maza, O., & Epeldegui, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4167 · Cited by 14

Non-Human Primate Models of HIV Brain Infection and Cognitive Disorders

Byrnes, S. J., Angelovich, T. A., Busman‐Sahay, K., Cochrane, C. R., Roche, M., Estes, J. D., & Churchill, M. J. (2022) · Viruses · doi:10.3390/v14091997 · Cited by 13

Traditional Cardiovascular Risk Factors Are Stronger Related to Carotid Intima‐Media Thickness Than to Presence of Carotid Plaques in People Living With HIV

Blaauw, M. J. T., Berrevoets, M. A. H., Vos, W. A. J. W., Groenendijk, A. L., van Eekeren, L. E., Vadaq, N., Weijers, G., van der Ven, A. J. A. M., Rutten, J. H. W., & Riksen, N. P. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030606 · Cited by 14

Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa

Riitho, V., Connon, R., Gwela, A., Namusanje, J., Nhema, R., Siika, A. M., Bwakura‐Dangarembizi, M., Musiime, V., Berkley, J. A., Szubert, A. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49317-7 · Cited by 14

T-Cell Depletion in the Colonic Mucosa of Patients With Idiopathic CD4+Lymphopenia

Kovacs, S. B., Sheikh, V., Thompson, W. L., Morcock, D. R., Pérez‐Díez, A., Yao, M. D., Rupert, A. W., Utay, N. S., Roby, G. A., Freeman, A. F., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv282 · Cited by 14

Brief Report

Olwenyi, O. A., Naluyima, P., Cham, F., Quinn, T. C., Serwadda, D., Sewankambo, N. K., Gray, R. H., Sandberg, J. K., Michael, N. L., Wabwire‐Mangen, F., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000915 · Cited by 14

Brief Report: Gut Structural Damage: an Ongoing Process in Chronically Untreated HIV Infection

Kamari, V. E., Sattar, A., & McComsey, G. A. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001910 · Cited by 14

Brief Report: Zinc Supplementation and Inflammation in Treated HIV

Dirajlal‐Fargo, S., Yu, J., Kulkarni, M., Sattar, A., Funderburg, N., Barkoukis, H. D., & McComsey, G. A. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002129 · Cited by 14

Gut microbiota dysbiosis is associated with worse emotional states in HIV infection

Pérez‐Santiago, J., Marquine, M. J., Cookson, D., Giraud-Colón, R., Heaton, R. K., Grant, I., Ellis, R. J., Letendre, S. L., & Peterson, S. N. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-020-00933-1 · Cited by 15

Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers

Fernandez-Botrán, R., Plankey, M. W., Ware, D. P., & Bordón, J. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155573 · Cited by 14

The Adenosine Pathway and Human Immunodeficiency Virus-Associated Inflammation

Hixson, E. A., Borker, P. V., Jackson, E. K., & Macatangay, B. J. C. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab396 · Cited by 15

A Dynamic Interplay of Circulating Extracellular Vesicles and Galectin-1 Reprograms Viral Latency during HIV-1 Infection

Rubione, J., Pérez, P. S., Czernikier, A., Duette, G., Gerber, F. P. P., Salido, J., Fabiano, M. P., Ghiglione, Y., Turk, G., Laufer, N., et al. (2022) · mBio · doi:10.1128/mbio.00611-22 · Cited by 13

Emerging clinical issues related to management of multiorgan comorbidities and polypharmacy

Vigouroux, C., Bastard, J., & Capeau, J. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000068 · Cited by 16

Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam

Bi, X., Ishizaki, A., Nguyen, L. V., Matsuda, K., Pham, H. V., Phan, C. T. T., Ogata, K., Giang, T., Phung, T., Nguyen, T. M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081245 · Cited by 14

Soluble CD14 as a Diagnostic Biomarker for Smear-Negative HIV-Associated Tuberculosis

Liu, Y., Ndumnego, O. C., Chen, T., Kim, R. S., Jenny-Avital, E. R., Ndung’u, T., Wilson, D., & Achkar, J. M. (2018) · Pathogens · doi:10.3390/pathogens7010026 · Cited by 14

Microbial translocation revisited

Storm-Larsen, C., Stiksrud, B., Eriksen, C., Nowak, P., Holm, K., Thalme, A., Dyrhol‐Riise, A. M., Brix, S., Hov, J. R., & Trøseid, M. (2018) · AIDS · doi:10.1097/qad.0000000000002087 · Cited by 14

HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation

Monnig, M. A., Cohen, R. A., Ramratnam, B., McAdams, M., Tashima, K. T., & Monti, P. M. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14032 · Cited by 16

Effect of Lactobacillus plantarum IS-10506 on blood lipopolysaccharide level and immune response in HIV-infected children

Athiyyah, A. F., Brahmantya, H., Dwiastuti, S., Darma, A., Puspitasari, D., Husada, D., Ranuh, R. G., Endaryanto, A., SURONO, I. S., & Sudarmo, S. M. (2019) · Iranian Journal of Microbiology · doi:10.18502/ijm.v11i2.1076 · Cited by 14

Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients

Lombardi, F., Belmonti, S., Borghetti, A., Ciccullo, A., Baldin, G., Cauda, R., Fabbiani, M., & Giambenedetto, S. D. (2019) · HIV Research & Clinical Practice · doi:10.1080/25787489.2019.1653512 · Cited by 14

Independent Association of Interleukin 6 With Low Dynamic Lung Function and Airflow Limitation in Well-Treated People With Human Immunodeficiency Virus

Thudium, R. F., Knudsen, A. D., von Stemann, J. H., Hove‐Skovsgaard, M., Hoel, H., Mocroft, A., Reekie, J., Ronit, A., Gerstoft, J., Vestbo, J., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa600 · Cited by 14

Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study

Frange, P., Montange, T., Chenadec, J. L., Batalie, D., Fert, I., Dollfus, C., Faye, A., Blanche, S., Chacé, A., Fourcade, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662894 · Cited by 14

Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients

Nouhin, J., Pean, P., Madec, Y., Chevalier, M. F., Didier, C., Borand, L., Blanc, F. –., Scott‐Algara, D., Laureillard, D., & Weiss, L. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.01.016 · Cited by 14

Direct Biomarkers of Microbial Translocation Correlate with Immune Activation in Adult Zambians with Environmental Enteropathy and Hepatosplenic Schistosomiasis

Kaonga, P., Kaimoyo, E., Besa, E. C., Zyambo, K., Sinkala, E., & Kelly, P. M. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0365 · Cited by 13

Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study

Mehta, K., Ravimohan, S., Pasipanodya, J. G., Srivastava, S., Modongo, C., Zetola, N. M., Weissman, D., Ivaturi, V. D., Gumbo, T., Bisson, G. P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz265 · Cited by 12

Inflammatory Mechanisms and Cascades Contributing to Neurocognitive Impairment in HIV/AIDS

Fernandes, N. C., & Pulliam, L. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_100 · Cited by 13

Subclinical Atherosclerosis Imaging in People Living with HIV

Schoepf, I. C., Buechel, R. R., Kovari, H., Hammoud, D. A., & TARR, P. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081125 · Cited by 13

Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV‐infected adults on a long‐term non‐nucleoside reverse transcriptase inhibitor‐based regimen

Allavena, C., Rodallec, A., Sécher, S., Reliquet, V., Baffoin, S., André‐Garnier, E., Billaud, E., Raffi, F., & Ferré, V. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23679 · Cited by 13

Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients

Charpentier, C., Champenois, K., Gervais, A., Landman, R., Joly, V., Gac, S. L., Larrouy, L., Damond, F., Brun‐Vézinet, F., Descamps, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059205 · Cited by 13

Vitamin D and Calcium Abnormalities in the HIV-Infected Population

Escota, G. V., Cross, S. L., & Powderly, W. G. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.05.005 · Cited by 13

Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy

Lankowski, A. J., Tsai, A. C., Kanyesigye, M., Bwana, M., Haberer, J. E., Wenger, M., Martin, J. N., Bangsberg, D. R., Hunt, P. W., & Siedner, M. J. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003036 · Cited by 13

Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use

Markowitz, M. H., Deren, S., Cleland, C. M., Mar, M. L., Silva, E., Batista, P., Bernard, L. S., Gettie, N., Rodriguez, K., Evering, T. H., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw373 · Cited by 13

Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial

Prebensen, C., Trøseid, M., Ueland, T., Dahm, A. E. A., Sandset, P. M., Aaberge, I. S., Waalen, K., Dyrhol‐Riise, A. M., Taskén, K., & Kvale, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176527 · Cited by 13

Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction

Brocca‐Cofano, E., Kuhrt, D. M., Siewe, B. T., Xu, C., Haret-Richter, G. S., Craigo, J. K., LaBranche, C. C., Montefiori, D. C., LANDAY, A. L., Apetrei, C., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01051-17 · Cited by 13

Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy

Ruggiero, A., Cozzi‐Lepri, A., Beloukas, A. I., Richman, D. D., Khoo, S., Phillips, A. N., Geretti, A. M., & ERAS Study Group (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy032 · Cited by 13

Human Immunodeficiency Virus and the Nervous System

Sutherland, E. J., & Brew, B. J. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.07.002 · Cited by 13

Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques

O’Connor, M. A., Munson, P. V., Tunggal, H. C., Hajari, N., Lewis, T. B., Bratt, D., Moats, C. R., Smedley, J. V., Bagley, K., Mullins, J. I., et al. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0184 · Cited by 11

Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder

Underwood, M. L., Nguyen, T. T., Uebelhoer, L. S., Kunkel, L. E., Korthuis, P. T., & Lancioni, C. (2019) · AIDS · doi:10.1097/qad.0000000000002416 · Cited by 14

CROI 2015: Complications of HIV Infection and Antiretroviral Therapy.

Havlir, D. V., & Currier, J. S. (2015) · Europe PMC (PubMed Central) · Cited by 13

Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy

Romero-Sánchez, M. C., Álvarez‐Ríos, A. I., Bernal, E., Genebat, M., Vera, F. J., Benhnia, M. R., Urbieta, J. B., Galera-Peñaranda, C., Pablo-Bernal, R. S. D., Abad-Carrillo, M. A., et al. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.08.011 · Cited by 13

Connecting the Dots: Could Microbial Translocation Explain Commonly Reported Symptoms in HIV Disease?

Wilson, N., Vance, D. E., Moneyham, L. D., Raper, J. L., Mugavero, M. J., Heath, S. L., & Kempf, M.-C. (2014) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2014.07.004 · Cited by 14

Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens

Funderburg, N., Huang, S. S. Y., Cohen, C. J., Ailstock, K., Cummings, M. J., Lee, J. C., Ng, B., White, K., Wallin, J. J., Downie, B., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1488799 · Cited by 12

Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection

Kießling, M., Cole, J. J., Kübel, S., Klein, P., Korn, K., Henry, A. R., Laboune, F., Fourati, S., Harrer, E. G., Harrer, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54605-3 · Cited by 18

Soluble CD14: An Independent Biomarker for the Risk of Mother-to-Child Transmission of HIV in a Setting of Preexposure and Postexposure Antiretroviral Prophylaxis

Shivakoti, R., Gupta, A., Ray, J. C., Uprety, P., Gupte, N., Bhosale, R. A., Mave, V., Patil, S., Balasubramanian, U., Kinikar, A. A., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv479 · Cited by 12

HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy

Toribio, M. P., Park, M. H., Zanni, M. V., Robbins, G. K., Burdo, T. H., Williams, K. C., Feldpausch, M. N., Stone, L. A., Melbourne, K. M., Grinspoon, S. K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01334 · Cited by 13

Sex modulates the association between inflammation and coronary atherosclerosis among older Ugandan adults with and without HIV

Shakil, S. S., Temu, T. M., Kityo, C. M., Nazzinda, R., Erem, G., Kentoffio, K., Bittencourt, M. S., Ntusi, N., Zanni, M. V., & Longenecker, C. T. (2022) · AIDS · doi:10.1097/qad.0000000000003451 · Cited by 12

Identification of drug candidates targeting monocyte reprogramming in people living with HIV

Knoll, R., Bonaguro, L., dos Santos, J. C., Warnat‐Herresthal, S., Cleophas, M. C. P., Blümel, E. P., Reusch, N., Horne, A., Herbert, M., Nuesch-Germano, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1275136 · Cited by 12

Heart failure in HIV infection

Ng, B., MacPherson, P., Haddad, T., & Dwivedi, G. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000041 · Cited by 12

Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals

Negi, N., Singh, R., Sharma, A. K., Das, B. K., & Vajpayee, M. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.08.004 · Cited by 12

Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV

Fourman, L. T., Czerwonka, N., Shaikh, S. D., Stanley, T. L., Burdo, T. H., Williams, K. C., Fitch, K. V., Lo, J., & Grinspoon, S. K. (2018) · AIDS · doi:10.1097/qad.0000000000001775 · Cited by 12

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers

Vitallé, J., Terrén, I., Gamboa-Urquijo, L., Orrantia, A., Tarancón‐Díez, L., Genebat, M., Ruíz-Mateos, E., Leal, M., García‐Obregón, S., Zenarruzabeitia, O., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01709 · Cited by 13

Brief Report: Higher Peripheral Monocyte Activation Markers Are Associated With Smaller Frontal and Temporal Cortical Volumes in Women With HIV

Kamkwalala, A. R., Wang, X., Maki, P. M., Williams, D. W., Valcour, V., Damron, A. L., Tien, P. C., Weber, K. M., Cohen, M. H., Sundermann, E. E., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002283 · Cited by 12

Endothelial Activation, Innate Immune Activation, and Inflammation Are Associated With Postbronchodilator Airflow Limitation and Obstruction Among Adolescents Living With HIV

Attia, E. F., Bhatraju, P. K., Triplette, M., Harju-Baker, S., Maleche‐Obimbo, E., West, T. E., Richardson, B. A., Zifodya, J. S., Eskander, S., Njiru, C. D., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002255 · Cited by 12

NOVEL MECHANISMS AND ANTI-INFLAMMATORY STRATEGIES TO REDUCE CARDIOVASCULAR RISK IN HUMAN IMMUNODEFICIENCY VIRUS.

Grinspoon, S. K. (2018) · Europe PMC (PubMed Central) · Cited by 12

Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individuals

Nayrac, M., Réquena, M., Loiseau, C., Cazabat, M., Suc, B., Carrère, N., Barange, K., Alric, L., Martin‐Blondel, G., Izopet, J., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0286-6 · Cited by 17

Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus–HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation

Anthony, D. D., Sulkowski, M., Smeaton, L. M., Damjanovska, S., Shive, C. L., Kowal, C. M., Cohen, D. E., Bhattacharya, D., Alston‐Smith, B., Balagopal, A., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa254 · Cited by 12

Novel Mechanism of Microvesicle Regulation by the Antiviral Protein Tetherin During HIV Infection

Weber, E. A., Singh, M. V., Singh, V. B., Jackson, J. W., Ture, S. K., Suwunnakorn, S., Morrell, C. N., & Maggirwar, S. B. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015998 · Cited by 10

Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation

Eckard, A. R., Hughes, H., Hagood, N. L., O’Riordan, M. A., Labbato, D. E., Kosco, J. C., Scott, S. E., & McComsey, G. A. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002538 · Cited by 12

SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise

Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12

Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy

Looby, S. E. D., Kantor, A., Burdo, T. H., Currier, J. S., Fichtenbaum, C. J., Overton, E. T., Aberg, J. A., Malvestutto, C., Bloomfield, G. S., Erlandson, K. M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac166 · Cited by 12

Role of translocated bacterial flagellin in monocyte activation among individuals with chronic HIV-1 infection

Svärd, J., Paquin‐Proulx, D., Buggert, M., Noyan, K., Barqasho, B., Sönnerborg, A. B., & Nowak, P. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.08.018 · Cited by 12

Predict Mortality in

(2016)

High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression

Krastinova, E., Lécuroux, C., Leroy, C., Seng, R., Cabie, A., Rami, A., Venet, A., Meyer, L., & Goujard, C. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv145 · Cited by 40

Elevated Levels of Serum-Soluble CD14 in Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Correlation to Disease Progression and Clinical Events

Lien, E., Aukrust, P., Sundan, A., Müller, F., Frøland, S. S., & Espevik, T. (1998) · Blood · doi:10.1182/blood.v92.6.2084 · Cited by 172

Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1–Infected West African Adults With High CD4 Counts

Affi, R., Gabillard, D., Dunyach‐Remy, C., Ntakpe, J.-B., Moh, R., Badjé, A., Kouamé, G. M., Karcher, S., Carrou, J. L., Danel, C., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002533 · Cited by 11

Study of the plasma levels of soluble CD14 in HIV infected patients

Maes, N. (2012) · Document Server@UHasselt (UHasselt)